DK1385492T3 - Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis - Google Patents

Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis

Info

Publication number: DK1385492T3
Authority: DK; Denmark
Prior art keywords: hyaluronic acid; acid derivatives; inflammatory arthritis; inhibit inflammatory; arthritis
Prior art date: 2000-10-19

Application number

DK01987663T

Other languages

Danish (da)

English (en)

Inventor

Rudolf Venbrocks

Andreas Roth

Peter-Juergen Mueller

Stephanie Moeller

Joerg Ozegowski

Gundela Peschel

Original Assignee

Wpmo Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-19

Filing date

2001-10-19

Publication date

2007-07-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1385492(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-10-19 Application filed by Wpmo Gmbh filed Critical Wpmo Gmbh

2007-07-30 Application granted granted Critical

2007-07-30 Publication of DK1385492T3 publication Critical patent/DK1385492T3/da

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
206010003246 arthritis Diseases 0.000 title abstract 2
230000002757 inflammatory effect Effects 0.000 title 1
229920002674 hyaluronan Polymers 0.000 abstract 3
229960003160 hyaluronic acid Drugs 0.000 abstract 2
206010023203 Joint destruction Diseases 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
208000037976 chronic inflammation Diseases 0.000 abstract 1
208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
238000011443 conventional therapy Methods 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
210000001503 joint Anatomy 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

DK01987663T 2000-10-19 2001-10-19 Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis DK1385492T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10053053A DE10053053A1 (de)	2000-10-19	2000-10-19	Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
PCT/DE2001/003984 WO2002032407A2 (fr)	2000-10-19	2001-10-19	Utilisation de derives d'acide hyaluronique pour inhiber les arthrites inflammatoires

Publications (1)

Publication Number	Publication Date
DK1385492T3 true DK1385492T3 (da)	2007-07-30

Family

ID=7661103

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01987663T DK1385492T3 (da)	2000-10-19	2001-10-19	Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis

Country Status (12)

Country	Link
US (2)	US20040053885A1 (fr)
EP (1)	EP1385492B1 (fr)
JP (1)	JP2004531460A (fr)
AT (1)	ATE357224T1 (fr)
AU (2)	AU2002221528B2 (fr)
CA (1)	CA2426083A1 (fr)
CY (1)	CY1106479T1 (fr)
DE (2)	DE10053053A1 (fr)
DK (1)	DK1385492T3 (fr)
ES (1)	ES2284714T3 (fr)
PT (1)	PT1385492E (fr)
WO (1)	WO2002032407A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10111165A1 (de) *	2001-03-02	2002-10-10	Knoell Hans Forschung Ev	Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen
JP2005239687A (ja) *	2004-02-27	2005-09-08	Nobuhiko Yui	嚢胞内投与薬
JP2008505086A (ja) *	2004-06-30	2008-02-21	イーエルシーマネージメントエルエルシー	Ｒｈｏｄｉｏｌａｒｏｓｅａを含む化粧組成物および方法
JP2007275388A (ja) *	2006-04-10	2007-10-25	Toshie Tsuchiya	細胞の分化を促進し、かつ炎症を抑制する人工器官
ITPD20060219A1 (it) *	2006-05-31	2007-12-01	Fidia Farmaceutici	Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
JP5088864B2 (ja) *	2007-03-16	2012-12-05	オリンパス株式会社	生体組織補填材とその製造方法
US10028976B2 (en) *	2007-07-02	2018-07-24	Aptissen Sa	Injectable formulation of natural polysaccharide and polyol for treatment of osteoarthritis
PT2252290T (pt) *	2008-02-15	2018-02-14	Bone Therapeutics Sa	Composição farmacêutica para utilização no tratamento e/ou prevenção de doenças osteoarticulares
US8343942B2 (en) *	2008-04-04	2013-01-01	University Of Utah Research Foundation	Methods for treating interstitial cystitis
CA2719666C (fr)	2008-04-04	2016-08-16	Glenn Prestwich	Ethers de glycoaminoglycosan semi-synthetiques alkyles et leurs procedes de fabrication et d'utilisation
IT1393945B1 (it)	2009-04-21	2012-05-17	Fidia Farmaceutici	Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche
IT1397246B1 (it)	2009-05-14	2013-01-04	Fidia Farmaceutici	Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
IT1397247B1 (it) *	2009-05-14	2013-01-04	Fidia Farmaceutici	Nuovi agenti regolatori dell'attivita' citochinica
US20130209531A1 (en)	2010-06-08	2013-08-15	University Of Utah Research Foundation	Applications of partially and fully sulfated hyaluronan
EP2688402B1 (fr)	2011-03-23	2018-10-24	University of Utah Research Foundation	Composés pour traiter ou prévenir une inflammation des voies urinaires
ITPD20120098A1 (it) *	2012-03-30	2013-10-01	Fidia Farmaceutici	"nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
US11337994B2 (en)	2016-09-15	2022-05-24	University Of Utah Research Foundation	In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
US10849914B2 (en)	2017-06-12	2020-12-01	University Of Utah Research Foundation	Methods for producing chemoembolic agents for the delivery of anti-cancer agents
KR20200031059A (ko)	2018-09-13	2020-03-23	주식회사 엘지화학	황산화 히알루론산 기반의 하이드로겔 및 이를 포함하는 약제학적 조성물
CN111228653A (zh)	2018-11-13	2020-06-05	格莱科米拉治疗公司	用电离辐射加强癌症治疗的方法
KR20200055645A (ko) *	2019-08-08	2020-05-21	고려대학교 산학협력단	황산화된 히알루론산 유도체, 이의 제조방법 및 이를 포함하는 근골격계 관절질환의 예방 또는 치료용 약학 조성물
KR102542329B1 (ko) *	2019-12-23	2023-06-13	주식회사 엘지화학	항염 또는 항혈관신생용 약제학적 조성물
IT202000032243A1 (it)	2020-12-23	2022-06-23	Fidia Farm Spa	Nuovi agenti antivirali

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5409904A (en) *	1984-11-13	1995-04-25	Alcon Laboratories, Inc.	Hyaluronic acid compositions and methods
SE8501723L (sv) *	1985-04-09	1986-10-10	Pharmacia Ab	Preparation att anvendas vid behandling av ledinflammation
FR2584728B1 (fr) *	1985-07-12	1987-11-20	Choay Sa	Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4808576A (en) *	1986-04-28	1989-02-28	Mobay Corporation	Remote administration of hyaluronic acid to mammals
CA1327354C (fr) *	1987-03-19	1994-03-01	David Cullis-Hill	Composes et compositions anti-inflamatoires
US5079236A (en) *	1987-05-27	1992-01-07	Hyal Pharmaceutical Corporation	Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
DE4021066A1 (de) *	1990-07-03	1992-01-09	Hoechst Ag	Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
AU1154992A (en) *	1991-01-30	1992-09-07	Hoechst Aktiengesellschaft	Use of substituted polysaccharides for the treatment of degenerative articular ailments
ITPD940054A1 (it) *	1994-03-23	1995-09-23	Fidia Advanced Biopolymers Srl	Polisaccaridi solfatati
DE69621528T2 (de) *	1995-02-07	2003-01-16	Shiseido Co. Ltd., Tokio/Tokyo	Anti-inflamatorische agenzien
US5922742A (en) *	1996-04-23	1999-07-13	Merck Frosst Canada	Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
AU738788B2 (en) *	1997-04-04	2001-09-27	Fidia Farmaceutici S.P.A.	N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
JPH11269077A (ja) *	1998-03-19	1999-10-05	Maruho Co Ltd	ホスホリパーゼａ２阻害用医薬組成物
WO2000056298A2 (fr) *	1999-03-19	2000-09-28	Luitpold Pharmaceuticals, Inc.	Traitement de la maladie de la lyme au moyen de formulations de glycosaminoglycans polysulfates
WO2000069917A1 (fr) *	1999-05-18	2000-11-23	Maruho Kabushikikaisha	Compositions medicinales destinees a inhiber le systeme kallikreine-kinine ou la phospholipase a¿2?

2000
- 2000-10-19 DE DE10053053A patent/DE10053053A1/de not_active Ceased
2001
- 2001-10-19 ES ES01987663T patent/ES2284714T3/es not_active Expired - Lifetime
- 2001-10-19 AT AT01987663T patent/ATE357224T1/de not_active IP Right Cessation
- 2001-10-19 DE DE50112247T patent/DE50112247D1/de not_active Revoked
- 2001-10-19 CA CA002426083A patent/CA2426083A1/fr not_active Abandoned
- 2001-10-19 WO PCT/DE2001/003984 patent/WO2002032407A2/fr not_active Ceased
- 2001-10-19 US US10/399,710 patent/US20040053885A1/en not_active Abandoned
- 2001-10-19 DK DK01987663T patent/DK1385492T3/da active
- 2001-10-19 EP EP01987663A patent/EP1385492B1/fr not_active Revoked
- 2001-10-19 AU AU2002221528A patent/AU2002221528B2/en not_active Ceased
- 2001-10-19 PT PT01987663T patent/PT1385492E/pt unknown
- 2001-10-19 AU AU2152802A patent/AU2152802A/xx active Pending
- 2001-10-19 JP JP2002535645A patent/JP2004531460A/ja active Pending
2006
- 2006-10-16 US US11/580,924 patent/US20070054878A1/en not_active Abandoned
2007
- 2007-06-20 CY CY20071100814T patent/CY1106479T1/el unknown

Also Published As

Publication number	Publication date
WO2002032407A2 (fr)	2002-04-25
HK1062524A1 (en)	2004-11-12
CA2426083A1 (fr)	2003-04-16
CY1106479T1 (el)	2012-01-25
EP1385492B1 (fr)	2007-03-21
AU2152802A (en)	2002-04-29
DE10053053A1 (de)	2002-05-16
US20070054878A1 (en)	2007-03-08
AU2002221528B2 (en)	2007-03-22
DE50112247D1 (de)	2007-05-03
EP1385492A2 (fr)	2004-02-04
ES2284714T3 (es)	2007-11-16
JP2004531460A (ja)	2004-10-14
PT1385492E (pt)	2007-06-29
US20040053885A1 (en)	2004-03-18
ATE357224T1 (de)	2007-04-15
WO2002032407A3 (fr)	2003-11-20

Publication	Publication Date	Title
DK1385492T3 (da)	2007-07-30	Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis
AR039688A1 (es)	2005-03-09	Preparaciones acidas de insulina con estabilidad mejorada
DK0975367T3 (da)	2004-07-26	Forbedret afgivelse af lægemidler til slimhindeoverflader
BR9813051A (pt)	2000-08-15	Formato estrutural para uso em construção de estrutura
JP2004531460A5 (fr)	2006-01-05
EA200401009A1 (ru)	2004-12-30	Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
DE602006014990D1 (de)	2010-07-29	Intranasale verabreichung von schnell wirkendem insulin
AR037260A1 (es)	2004-11-03	Formulaciones de proteinas de liberacion sostenida acuosas
EP2289523A3 (fr)	2011-09-28	Regimes pour viscosupplementation intra-articulaire
EE05072B1 (et)	2008-10-15	Farmatseutilised kompositsioonid limaskestale kandmiseks
AR044050A1 (es)	2005-08-24	Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos
DE60103627D1 (de)	2004-07-08	SELBSTEMULGIERENDES ARZNEISTOFFVERABREICHUNGSSYSTEM, wobei das Fettmittel optional ist
ATE541562T1 (de)	2012-02-15	Ibuprofen-suspension
NO993066L (no)	1999-06-21	Ny behandling for leddinflammasjon
BR0316493A (pt)	2005-10-11	ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres
AR043418A1 (es)	2005-07-27	Formulaciones liquidas de las proteinas de union del factor necrosis del tumor
HRP20050557A2 (en)	2006-05-31	Method for improving the pharmacokinetics of a nnrti
BRPI0412430A (pt)	2006-09-05	polipeptìdeo agonista do receptor de zot e zonulina
FR3109077B1 (fr)	2024-04-19	Implant d’ancrage osseux à expansion optimisée
BR112022008192A2 (pt)	2022-07-12	Queratina bd-4, sua preparação e composições farmacêuticas e uso
Smith et al.	2002	A role for histamine in cytokine modulation by the adenosine A3 receptor agonist, 2-Cl-IB-MECA
AR022462A1 (es)	2002-09-04	Uso de un agente que disminuye el colesterol
DK1276477T3 (da)	2004-04-13	Medikamenter indeholdende pantothensyre til behandlingen af inflammatorisk ledsygdom
BR0007513A (pt)	2001-11-20	Fosfatidilinositóis sulfatados, sua preparação euso
BR0009778A (pt)	2002-01-02	Composições antifúngicas de pseudomicina e métodos para utilização das mesmas